Short and long term mortality associated with foodborne bacterial gastrointestinal infections: Registry based study

British Medical Journal

Volumn 326, Issue 7385, 2003, Pages 357-359

  Helms, Morten ^a   Vastrup, Pernille ^a   Gerner Smidt, Peter ^b   Mølbak, Kåre ^b  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAMPYLOBACTER; CONTROLLED STUDY; FOOD CONTAMINATION; GASTROINTESTINAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SALMONELLA; SHIGELLA; YERSINIA ENTEROCOLITICA;

BACTERIAL INFECTIONS; COHORT STUDIES; COMORBIDITY; DENMARK; FOOD POISONING; GASTROINTESTINAL DISEASES; HUMANS; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0037442937     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Todd EC. Epidemiology of foodborne diseases: a worldwide review. World Health Stat Q 1997;50:30-50.
2. De Wit MA, Hoogenboom-Verdegaal AM, Goosen ES, Sprenger MJ, Borgdorff MW. A population-based longitudinal study on the incidence and disease burden of gastroenteritis and Campylobacter and Salmonella infection in four regions of the Netherlands. Eur J Epidemiol 2000;16:713-8.
3. Potter ME, Tauxe RV. Epidemiology of foodborne diseases: tools and applications. World Health Stat Q 1997;50:24-9.
4. Altekruse SF, Cohen ML, Swerdlow DL. Emerging foodborne diseases. Emerg Infect Dis 1997;3:285-93.
5. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-25.
6. Mauskopf JA, French MT. Estimating the value of avoiding morbidity and mortality from foodborne illnesses. Risk Anal 1991;11:619-31.
7. Banatvala N, Cramp A, Jones IR, Feldman RA. Salmonellosis in North Thames (East), UK: associated risk factors. Epidemiol Infect 1999;122:201-7.
8. Mosbech J, Jorgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. [The national patient registry. Evaluation of data quality.] Ugeshr Laeger 1995;157:3741-5. (In Danish.)
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
10. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
11. Cleves MA, Sanchez N, Draheim M. Evaluation of two competing methods for calculating Charlson's comorbidity index when analysing short-term mortality using administrative data. J Clin Epidemiol 1997;50:903-8.
12. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993;32:382-7.
13. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Gharlson comorbidity index with administrative data bases. J Clin Epidemiol 1996;49:1429-33.
14. Lester A, Bruun BG, Husum P, Kolmos HJ, Nielsen BB, Scheibel JH, et al. [Salmonella Dublin]. Ugeskr Laeger 1995;157:20-4.
15. Lester A, Eriksen NH, Nielsen H, Nielsen PB, Friis-Møller A, Bruun BG, et al. [Bacteremia caused by zoonotic Salmonella types in greater Copenhagen in 1984-1988]. Ugeskr Laeger 1990;152:529-32.
16. Fang FC, Fierer J. Human infection with Salmonella Dublin. Medicine (Baltimore) 1991;70:198-207.
17. Cohen ML, Tauxe RV. Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science 1986;234:964-9.
18. Ryan CA, Nickels MK, Hargrett-Bean NT, Potter ME, Endo T, Mayer L, et al. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA 1987;258:3269-74.
19. Helms M, Vastrup P, Gerner-Smidt P, Mølbak K. Excess mortality associated with antimicrobial drug-resistant, particular quinolone-resistant, Salmonella typhimurium. Emerg Infect Dis 2002;8:490-5.